These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7540960

  • 1. Histopathological and immunohistochemical analysis of adenomatous hyperplasia and hepatocellular carcinoma: cellularity, thickness of cell cord, and Ki-67 proliferative activity.
    Than KW, Okayasu I, Akashi T.
    Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):67-81. PubMed ID: 7540960
    [Abstract] [Full Text] [Related]

  • 2. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [Abstract] [Full Text] [Related]

  • 3. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE.
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [Abstract] [Full Text] [Related]

  • 4. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.
    Kaji K, Terada T, Nakanuma Y.
    Am J Gastroenterol; 1994 Jun; 89(6):903-8. PubMed ID: 8198103
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopathological significance of adenomatous hyperplasia of the liver].
    Nakashima O, Kojiro M.
    Nihon Rinsho; 1994 Jan; 52(1):75-9. PubMed ID: 8114314
    [Abstract] [Full Text] [Related]

  • 6. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T, Hoso M, Nakanuma Y.
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [Abstract] [Full Text] [Related]

  • 7. [Immunohistochemical study of hepatitis C virus core antigen and HBxAg in liver cirrhosis and hepatocellular carcinoma tissues].
    Wang C, Wang W, Lu H.
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):85-8. PubMed ID: 10743066
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
    Maeda T, Takenaka K, Taguchi K, Kajiyama K, Shirabe K, Shimada M, Tsuneyoshi M, Sugimachi K.
    Hepatogastroenterology; 2000 Mar; 47(32):498-503. PubMed ID: 10791221
    [Abstract] [Full Text] [Related]

  • 9. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W.
    Pol J Pathol; 1997 Mar; 48(3):147-57. PubMed ID: 9401407
    [Abstract] [Full Text] [Related]

  • 10. [Precancerous stages of hepatocellular carcinoma].
    Tanikawa K.
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2055-61. PubMed ID: 8607615
    [Abstract] [Full Text] [Related]

  • 11. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA, Nap M, Huitema S, Krom RA, Houthoff HJ.
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [Abstract] [Full Text] [Related]

  • 12. [Pathomorphologic characteristics and differential diagnosis of small hepatocellular carcinoma].
    Nakashima O, Kojiro M.
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):827-34. PubMed ID: 8678529
    [Abstract] [Full Text] [Related]

  • 13. [Clinical significance of telomerase activity in precancerous lesion of the liver (adenomatous hyperplasia)].
    Nishimoto A, Miura N, Oshimura M.
    Nihon Rinsho; 1998 May; 56(5):1244-7. PubMed ID: 9613131
    [Abstract] [Full Text] [Related]

  • 14. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen.
    Terada T, Nakanuma Y.
    Cancer; 1992 Aug 01; 70(3):591-8. PubMed ID: 1352480
    [Abstract] [Full Text] [Related]

  • 15. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.
    Hepatology; 1996 Jun 01; 23(6):1304-12. PubMed ID: 8675143
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
    Nonomura A, Ohta G, Hayashi M, Izumi R, Watanabe K, Takayanagi N, Mizukami Y, Matsubara F.
    Am J Gastroenterol; 1987 Jun 01; 82(6):512-8. PubMed ID: 3034055
    [Abstract] [Full Text] [Related]

  • 17. Pathomorphologic comparison of hepatitis C virus-related and hepatitis B virus-related cirrhosis bearing hepatocellular carcinoma.
    Kojiro M, Shimamatsu K, Kage M.
    Princess Takamatsu Symp; 1995 Jun 01; 25():179-84. PubMed ID: 8875623
    [Abstract] [Full Text] [Related]

  • 18. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S.
    Int J Oncol; 2005 Mar 01; 26(3):661-71. PubMed ID: 15703821
    [Abstract] [Full Text] [Related]

  • 19. Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma.
    Morinaga S, Ishiwa N, Noguchi Y, Yamamoto Y, Rino Y, Imada T, Takanashi Y, Akaike M, Sugimasa Y, Takemiya S.
    J Surg Oncol; 2005 Dec 15; 92(4):331-6. PubMed ID: 16299800
    [Abstract] [Full Text] [Related]

  • 20. CD 34 expression in chronic and neoplastic liver diseases.
    Di Carlo I, Fraggetta F, Lombardo R, Azzarello G, Vasquez E, Puleo S.
    Panminerva Med; 2002 Dec 15; 44(4):365-7. PubMed ID: 12434120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.